Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-473-6 | CAS number: 121-47-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2011 - 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- 3-aminobenzenesulphonic acid
- EC Number:
- 204-473-6
- EC Name:
- 3-aminobenzenesulphonic acid
- Cas Number:
- 121-47-1
- Molecular formula:
- C6H7NO3S
- IUPAC Name:
- 3-aminobenzene-1-sulfonic acid
- Details on test material:
- - Name of test material (as cited in study report): 3-aminobenzene sulphonic acid; metanilic acid
- Analytical purity: 99.6% (neutralization titration), 98.3% (HPLC)
- Lot/batch No.: 45JPG
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source (i.e. manufacturer or supplier) and lot/batch number of test material: 45JPG
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
The test substance was analyzed by the study consignee on completion of the animal study, and was confirmed as having been stable throughout the period of the animal study
- Storage condition of test material: Cool dark place (measured value: 2-8°C), tightly sealed
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Details on species / strain selection:
- SPF mice [Crlj:CD1(ICR), Atsugi Breeding Center, Charles River Laboratories Japan, Inc.]
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Institute of Cancer Research
- Age at study initiation: 7 weeks
- Weight at study initiation: 35.8-41.6 g for the males and 28.7-32.2 g for the females
- Assigned to test groups randomly: [no/yes, under following basis: ] yes
- Housing: The animals were housed individually in plastic cages (W 155 D 245 H 150 mm Clea Japan Inc.) provided with floor covering (white flake, Charles River Laboratories Japan), in an animal rearing room (Rearing Room Number: Room 101 for preliminary study,
- Diet (e.g. ad libitum): . Solid feed CRF-1 (Oriental Yeast )Co., Lot No. 110908
- Water (e.g. ad libitum): drinking water (Gotemba City tap water, using water bottles)
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24°C
- Humidity (%): (acceptable range 50±20%) 46-56% for the preliminary study and 42-55% for the main study
- Air changes (per hr): 10-15 times per hour
- Photoperiod (hrs dark / hrs light): 12 hours a day (07:00-19:00)/12 hours dark (19:00-7:00)
Administration / exposure
- Route of administration:
- oral: unspecified
- Vehicle:
- Sodium carboxymethylcellulose
Doses / concentrationsopen allclose all
- Dose / conc.:
- 250 mg/kg bw/day (nominal)
- Dose / conc.:
- 500 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Dose / conc.:
- 2 000 mg/kg bw/day (nominal)
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Negative controls validity:
- valid
- Positive controls validity:
- valid
Applicant's summary and conclusion
- Conclusions:
- 3-Aminobenzenesulfonic acid was administered at 250, 500, 1000 and 2000 mg/kg/day.. On observation of the general condition, colored urine (orange-yellow) was observed in all males and females in each test substance administration group. There were no deaths. No decrease in body weight related to test substance administration was observed. There were no observed changes in general condition in the negative control group or in the positive control group. There were no observed abnormalities in body weight variation in any test substance administration group compared to the negative control group. There were no observed abnormalities in body weight variation in the positive control group. In the test substance administration groups, the MNPCE frequency was 0.12 ± 0.08% in the 500 mg/kg/day group, 0.14 ± 0.11% in the 1000 mg/kg/day group and 0.11 ± 0.04% in the 2000 mg/kg/day group. Comparing these values with the negative control group of 0.11 ±0.05%, no statistically significant increase or dose dependent change was observed in any of the test substance administration groups. There were no statistically significant (p<0.05) changes in the PCE frequency in 200 total erythrocytes in any test substance administration group compared to the negative control group. The MNPCE frequency in the positive control group was markedly higher than in the negative control group. Furthermore, the MNPCE frequencies in the negative control group and the positive control group were within the range of mean ± 3 S.D. of the study laboratory background data.
- Executive summary:
A micronucleus study was conducted using Crlj:CD1(ICR) SPF mice, in order to investigate whether or not 3-aminobenzenesulfonic acid induces chromosomal aberration. In the preliminary study for determining the doses, 250, 500, 1000 and 2000 mg/kg/day,respectively, was administered orally twice at an interval of about 24 hours, to 3 males and 3 females in each group; observation of general condition revealed that, as a result, all males and females in each test substance administration group exhibited colored urine (orange-yellow). There were no deaths. There were no decreases in body weight relating to test substance administration. Based on the above results, there were no deaths in the preliminary study wherein the maximum dose was 2000 mg/kg/day, and so in the main study, 2000 mg/kg/day was set as the high dose, and this was divided by a common ratio of 2 to give doses of 1000 and 500 mg/kg/day; these doses were administered orally twice at an interval of about 24 hours. Bone marrow smear samples were produced and observed about 24 hours after the second administration. Moreover, a negative control group and a positive control group were established; the negative control group received aqueous 0.5% CMC-Na solution at the same administration frequency as in the test substance administration group, and the positive control received a single administration of 1 mg/kg mitomycin C, and at the prescribed time after administration, bone marrow smear samples were prepared and observed. Five male animals were used per group. The results revealed no statistically significant increase in MNPCE frequency in any test substance administration group compared to the negative control group, and no dose-dependent changes were observed. Furthermore, there was no statistically significant change in the PCE frequency in 200 total erythrocytes in any test substance administration group compared to the negative control group. The MNPCE frequencies in the negative control and positive control groups were within the range of mean ± 3 S.D. of the study laboratory background data, and so the test was thought to have been conducted appropriately. It was judged from the above results that, under the conditions of this study, 3-aminobenzenesulfonic acid does not induce chromosomal aberration in the bone marrow of Crlj:CD1(ICR) SPF mice.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.